Dr. Hong Xu, MD

Dr. Xu practices at Rheumatology Associates of L.I. in Port Jefferson Station, New York.

Dr. Xu's NPI, 1922064625, was assigned on April 22, 2006. Dr. Xu graduated from Shanghai Medical University in 1991. Dr. Xu holds New York license 235086.

Dr. Xu's primary practice is Rheumatology Associates of L.I., at 7 Medical Dr, Port Jefferson Station, NY 11776 in Suffolk County. The practice phone is (631) 360-7778.

Dr. Xu's primary practice is Rheumatology Associates of L.I. in Port Jefferson Station, New York. Dr. Xu is also affiliated with Stony Brook University Hospital. The medical group on file is Rheumatology Associates of Long Island. Dmand AI also links Dr. Xu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Xu practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Xu's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Xu is licensed in New York.

CMS data shows 163,831 Medicare services from Dr. Xu across 31 procedure codes in 2024, for 890 Medicare patients. Medicare paid $1,910,412 for them. Every service was in an office.

CMS counts 890 Medicare patients who saw Dr. Xu in 2024. The largest group is 65 to 74, with 367 patients. 75% of them have arthritis, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Xu's median patient age at 65, with 74% women.

In 2024, Dr. Xu wrote 2,829 Medicare Part D claims for 543 patients. 79% of them were for generic drugs. CMS names the drug for 2,546 of them, across 37 drugs with 11 or more claims each, at $4,411,217 in total drug cost. In 2023, CMS named 2,157 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Xu for performance year 2024, reported as part of a group. Dr. Xu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Xu as offering telehealth.

Dmand AI links 19 papers to Dr. Xu, published from 2013 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Surgery, Plastic, Artificial Intelligence and Plastic Surgery Procedures. Dr. Xu has published most often in Aesthet Surg J. Dr. Xu's most frequent co-authors are Joshua Joseph Vorstenbosch, MD, PhD, FRCSC, Brian Bassiri-Tehrani, MD and Foad Nahai, MD.

CMS Open Payments shows 2,116 general payments to Dr. Xu from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Abbvie Inc. paid the most, $25,757.

Dr. Xu graduated from Shanghai Medical University in 1991.